217. Long-Term 52-Week Results of Palace 1, A Phase 3,...

Rheumatology 2014 / 04 Vol. 53; Iss. suppl_1

217. Long-Term 52-Week Results of Palace 1, A Phase 3, Randomized, Controlled Trial of Apremilast, an Oral Phosphodiesterase Inhibitor, In atients with Psoriatic Arthritis

Adebajo, Adewale O., Kavanaugh, Arthur, Mease, Philip J., Wollenhaupt, Jürgen, Hu, ChiaChi, Shah, Kamal, Stevens, Randall M., Gomez-Reino, Juan J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
53
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/keu115.011
Date:
April, 2014
File:
PDF, 34 KB
english, 2014
Conversion to is in progress
Conversion to is failed